Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Neoplasm Metastasis 10Lung Neoplasms 9Carcinoma, Medullary 9Neoplasms 6Thyroid Neoplasms 5Glioma 5Glioblastoma 5Gliosarcoma 4Colorectal Neoplasms 4Brain Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Familial medullary thyroid carcinoma 2Disease Progression 2Colonic Neoplasms 2Carcinoma, Squamous Cell 2Biliary Tract Neoplasms 2Waldenstrom Macroglobulinemia 1Urethral Neoplasms 1Ureteral Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Recurrence 1

Interventions

vandetanib 1pazopanib 1Surgical Procedures, Operative 16-chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-ylamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × GIST × vandetanib × Clear all
NCT02015065 2020-03-30

Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
9 enrolled 14 charts
Sarcoma

GIST

Data powered by HemOnc (CC BY 4.0) Colophon âš¡